Perrigo Company plc (NYSE:PRGO – Free Report) – Equities research analysts at Zacks Research decreased their Q1 2025 earnings per share estimates for Perrigo in a research report issued to clients and investors on Thursday, March 20th. Zacks Research analyst S. Ganoria now expects that the company will post earnings of $0.44 per share for the quarter, down from their prior estimate of $0.52. The consensus estimate for Perrigo’s current full-year earnings is $2.56 per share. Zacks Research also issued estimates for Perrigo’s Q2 2025 earnings at $0.70 EPS, Q3 2025 earnings at $0.79 EPS, FY2025 earnings at $2.93 EPS, Q1 2026 earnings at $0.55 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $0.83 EPS, Q4 2026 earnings at $0.99 EPS, FY2026 earnings at $3.20 EPS and FY2027 earnings at $3.51 EPS.
Perrigo (NYSE:PRGO – Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion during the quarter, compared to analyst estimates of $1.20 billion.
Check Out Our Latest Analysis on Perrigo
Perrigo Stock Performance
PRGO stock opened at $27.73 on Monday. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. Perrigo has a 1-year low of $23.14 and a 1-year high of $33.46. The business has a 50-day moving average price of $25.80 and a 200 day moving average price of $26.14. The company has a market capitalization of $3.78 billion, a P/E ratio of -23.70 and a beta of 0.48.
Perrigo Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th will be issued a $0.29 dividend. This is a boost from Perrigo’s previous quarterly dividend of $0.28. This represents a $1.16 dividend on an annualized basis and a dividend yield of 4.18%. The ex-dividend date of this dividend is Friday, March 7th. Perrigo’s dividend payout ratio (DPR) is currently -92.80%.
Insider Transactions at Perrigo
In other news, EVP Ronald Craig Janish sold 7,800 shares of the firm’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the sale, the executive vice president now owns 33,666 shares of the company’s stock, valued at $923,795.04. This trade represents a 18.81 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.70% of the company’s stock.
Institutional Investors Weigh In On Perrigo
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. California State Teachers Retirement System grew its stake in shares of Perrigo by 11.4% during the fourth quarter. California State Teachers Retirement System now owns 145,760 shares of the company’s stock worth $3,747,000 after acquiring an additional 14,893 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in Perrigo by 9.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 23,149 shares of the company’s stock worth $595,000 after purchasing an additional 1,968 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Perrigo during the 4th quarter worth approximately $383,000. University of Texas Texas AM Investment Management Co. increased its stake in Perrigo by 12.0% during the 4th quarter. University of Texas Texas AM Investment Management Co. now owns 38,424 shares of the company’s stock valued at $988,000 after purchasing an additional 4,105 shares in the last quarter. Finally, Novem Group purchased a new position in shares of Perrigo in the fourth quarter worth $2,601,000. 95.91% of the stock is currently owned by hedge funds and other institutional investors.
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also
- Five stocks we like better than Perrigo
- How to Capture the Benefits of Dividend Increases
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How to Find Undervalued Stocks
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.